Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
309.60    1.20 (0.39%)
Bid:
310.60
Ask:
313.60
Spread: 3.00 (0.966%)
Market Cap: £678.24m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Statement on AGM Proposals

6 May 2020 08:30

RNS Number : 1026M
Burford Capital Limited
06 May 2020
Ā 

Ā 

6 May 2020

Ā 

Ā 

BURFORD CAPITAL STATEMENT ON AGM PROPOSALS

Ā 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today issued the following statement concerning the proposals circulated for consideration at its forthcoming AGM.

Ā 

As discussed in the Chairman's letter to shareholders, the primary purpose of the proposed amendments to the Articles and the Company's long-term incentive plan is to make them fit for purpose for Burford's anticipated US listing. There are a number of provisions in Burford's Articles, which have not been amended meaningfully since the Company's founding more than a decade ago as a listed fund, that are inconsistent with US practice. The Company has also used this opportunity to refresh the Articles to current Guernsey best practice as advised by leading counsel there.

Ā 

By moving to a dual listing, shareholders in both countries will need to find common ground to arrive at a mutually viable set of Articles for the Company. There are governance points that are commonplace in the UK that would not be typically seen in the US and vice versa. Rigid adherence to a UK market approach risks a situation where Burford's governance is too far afield from US norms for a US listing to be viable.

Ā 

Burford developed the proposed amended Articles through a consultation process involving leading counsel in London, New York and Guernsey, with an effort to reach a set of Articles viable for shareholders in all jurisdictions. Burford explains below the background to certain points raised by ISS and Glass Lewis (without any prior consultation with the Company), and also sets out one modification to the LTIP proposal.

Ā 

The Board strongly recommends a vote in favor of the resolutions proposed at the AGM.

Ā 

LTIP

Ā 

The Company withdraws the proposed amended section 3.4 of the Plan Rules that has attracted negative commentary from ISS and Glass Lewis. While the proposed changes are commonplace in US practice, it is not vital to accommodate that practice on this occasion. The Company has amended the LTIP documents on its website to reflect that no changes shall be made to the existing LTIP approach in this regard.

Ā 

Neither ISS and Glass Lewis nor shareholders have identified any other concerns with the proposed LTIP amendments and thus the Company assumes that ISS and Glass Lewis will modify their voting recommendation to support the proposed amendments.

Ā 

Articles

Ā 

It is the Company's view that the proposed amendments to the Articles, viewed holistically, improve the Company's governance and provide additional significant protections to shareholders. For example, Burford is proposing to eliminate its staggered Board and move to annual elections of all directors. Burford has also modernized the Articles in numerous other ways, including specifically authorizing shareholder proposals to be raised at AGMs and permitting shareholders to nominate candidates for directorships.

Ā 

ISS has not, however, weighed either the net consequence of the amendments nor their impact on the US listing, and has instead taken issue with four specific points from a purely UK perspective, as to which we comment here. Notably, Glass Lewis does not share ISS' concerns and has recommended a vote in favor of the amendments to the Articles.

Ā 

1. While not acknowledging the governance benefit of the elimination of the Company's staggered board (a US governance imperative), ISS objects to the possibility of annual director elections occurring on a slate instead of an individual basis. To be clear, the Company does not intend to make use of slate-based elections but having the option to do so is essentially the quid pro quo of moving away from a staggered board.

2. ISS applies UK law to object to the notice period for calling shareholder meetings, but the notice period set forth in the Articles of ten days is (i) pursuant to and consistent with Guernsey law, which governs Burford, and (ii) the same as it is presently in the current Articles. The amendment merely adds the word "calendar" given US practice in needing to define the number of days as "calendar" or "business". This is an inappropriate objection to something the substance of which is not changing in the Articles.

3. The Company has proposed the removal of an obsolete limitation on its borrowing powers in the Articles that dates to the period when Burford was a listed investment fund and focused on borrowing as a percentage of announced NAV. Burford is of course no longer a fund and is subject to borrowing limitations in its public debt, and does not pursue a highly leveraged strategy. It is inconsistent with US practice to include a borrowing limit in the Articles and this is a place where we suggest compromise is needed.

4. The proposed Articles, in keeping with US practice, do not contain a limit on director compensation, and there are many other ways to address compensation overreach. Again, we suggest compromise is needed.

Ā 

At bottom, in deciding how to vote on the proposed amendments to the Articles, shareholders will need to decide (i) whether the incremental benefits and protections obtained outweigh these four points and (ii) the relative importance they place on a US listing. The Board strongly recommends a vote in favor to enable the US listing process to proceed without further delay.

Ā 

Director tenure

Ā 

Burford has set out a comprehensive plan for refreshing and rotating the board, along with a clear and definite transition schedule. That plan has received considerable shareholder support. However, ISS ignores that plan and also ignores the Company's governing law (Guernsey) and its adherence to the Guernsey Financial Sector Code of Corporate Governance, and Glass Lewis misstates the relevant Code, saying incorrectly that the Company elected to adopt the UK Corporate Governance Code. As a result, two directors are incorrectly classified as non-independent in both firms' reports when they are in fact independent under the Guernsey Code. Given that David Lowe is also retiring at the forthcoming AGM, the Company's clearly articulated transition plan would be materially disrupted if three of its four directors were to be summarily removed from the Board at the AGM next week as suggested by the voting recommendations.

Ā 

Ā 

For further information, please contact:

Ā 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

Ā 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

Ā 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

Ā 

For more information about Burford: www.burfordcapital.com

Ā 

Ā 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
STRDQLBBBELBBBE
Date   Source Headline
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close
10th Jun 20223:00 pmRNSIntended Purchases of Ordinary Shares
7th Jun 20223:00 pmRNSNotification of Major Holdings
1st Jun 20223:00 pmRNSRetail Shareholder Call Registration Details
1st Jun 202210:00 amRNSSterling FX Rate for 2021 Final Dividend
26th May 202212:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSExtension of SWF Arrangement & Fund Management
25th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
24th May 20223:30 pmRNSDirector/PDMR Shareholding
24th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
23rd May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
20th May 20225:38 pmRNSResult of AGM
20th May 20224:17 pmRNSPricing of Early Redemption of Bonds Due 2022
20th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
19th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
18th May 20228:00 amRNSNotice of Retail Shareholder Call on June 16, 2022
18th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
17th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
16th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
13th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
10th May 20228:00 amRNSNotice of Early Redemption of Bonds Due 2022
19th Apr 20227:00 amRNSAccess to Summary Judgment Filings in YPF Cases
13th Apr 20225:39 pmRNSCompleted Share Purchase by Employee Benefit Trust
13th Apr 202212:00 pmRNSNotice of 2022 AGM
12th Apr 20227:00 amRNSClosing of Private Offering of Senior Notes
11th Apr 20227:00 amRNSChristopher A. Halmy Nominated as Board Director
8th Apr 202211:30 amRNSDirector/PDMR Shareholding
7th Apr 20227:05 amRNSPricing and Upsizing of Senior Notes Offering
6th Apr 202211:30 amRNSDirector/PDMR Shareholding
4th Apr 20221:15 pmRNSPrivate Offering of Senior Notes
4th Apr 20227:00 amRNSManagement Team Invest $3 Million in Burford Stock
1st Apr 20225:59 pmRNSIntended Purchases of Ordinary Shares
29th Mar 202212:43 pmRNSAvailability of Annual Report
29th Mar 202212:13 pmRNSFull Year Results 2021
28th Mar 20227:00 amRNS$360m Pre-Settlement Investment Fund Close
15th Mar 202212:00 pmRNSNotice of FY21 Earnings Call Details
4th Mar 202212:00 pmRNSNotice of FY21 Results & Earnings Call
1st Mar 20224:53 pmRNSBurford Capital - $100m Equity Project Commitments
15th Feb 20227:00 amRNSUpdate on 2021 Business Activity & Accounting
8th Feb 20223:10 pmRNSBurford Capital's Affirmative Recovery Research
19th Jan 20224:30 pmRNSTR1 - Notification of Major Holdings
24th Dec 202110:00 amRNSTR1 - Notification of Major Holdings
23rd Dec 20217:00 amRNSStatement concerning non-cash accrual
15th Nov 20213:00 pmRNSSterling FX Rate for 2021 Interim Dividend
3rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:57 amRNSMaterials for Investor Event
12th Oct 20212:00 pmRNSNotice of Investor Event Registration Details
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
27th Sep 20218:30 amRNSCompleted Share Purchase by Employee Benefit Trust

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.